Investigating recruitment and activity of the BRCA1-A complex on chromatin

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

June 29, 2029
Response Due
Active
Status

Opportunity Overview

Our DNA is constantly exposed to damage from natural processes inside the cell as well as from environmental factors such as radiation and chemicals. Cells rely on intricate molecular systems to repair this damage and prevent the harmful mutations that can lead to cancer. One of the most important of these systems is controlled by BRCA1, a tumour suppressor protein frequently mutated in breast and ovarian cancer.
BRCA1 does not act alone. It functions within large molecular machines, including the BRCA1-A complex, which helps to control how DNA double-strand breaks are detected and repaired. This complex is thought to prevent inappropriate processing of broken DNA ends, ensuring that repair happens in a controlled way. However, many fundamental questions remain unanswered. We do not fully understand how the BRCA1-A complex assembles, how it is recruited to damaged DNA, how its component enzymes cooperate or compete, and how the repair process is switched off once the DNA is restored. These gaps in knowledge are critical, as failure to regulate these steps contributes to cancer development and treatment resistance.
Our project will directly address these questions. Using structural biology, chemical biology, biochemistry and cell biology, we will study how BRCA1-A recognises the molecular “tags” placed on DNA and chromatin during damage. These tags include chains of ubiquitin and SUMO, which act like signals to recruit and regulate repair factors. We will investigate how BRCA1-A binds and processes these signals, how its subunits assemble into a functional supercomplex, and how its two opposing enzyme activities — one that removes ubiquitin chains and one that adds them — are coordinated. Importantly, we will reconstitute the entire 1.5 MDa BRCA1-A complex with defined, site-specifically modified chromatin substrates. This has never been achieved before and represents a major technical advance.
Our team brings together complementary expertise: structural biology of...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedJune 29, 2026
Procurement stageActive solicitation
Response dueJune 29, 2029
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.